Translating Scientific Breakthroughs into Promise for Patients

From discovery through commercialization, all of us at Ardelyx® are driven to advance patient care with targeted, first-in-class, novel mechanism therapies that address significant unmet medical needs. We developed a unique and innovative platform that enabled the discovery of new biological mechanisms and pathways to create targeted, first-in-class, oral, small molecule therapies.

With Integrity and Dedication, We Make a Difference for Patients

Join Us

We are… Passionate. Fearless. Dedicated. Inclusive!

Patients & Families

Translating scientific breakthroughs into promise for patients.

For Investors

Creating value from

Recent News

November 30, 2021

Ardelyx Launching IBSRELA® Second Quarter of 2022

November 12, 2021

Ardelyx Reports Third Quarter 2021 Financial Results

November 11, 2021

Ardelyx to Present at the Jefferies London Healthcare Conference